- JP-listed companies
- TAUNS Laboratories, Inc.
- Income statement
TAUNS Laboratories, Inc.【JP:197A】Income statement
Market cap
¥56.6B
P/E ratio
6.5x
| 2019/06 | 2020/06 | 2021/06 | 2022/06 | 2023/06 | 2024/06 | 2025/06 | |
| Revenue | - | - | - | 17,457 | 15,673 | 18,435 | 18,628 |
| Revenue growth (%) | - | - | - | - | |||
| Cost of revenue | - | - | - | 2,775 | 6,473 | 5,937 | 5,853 |
| Gross profit | - | - | - | 14,682 | 9,200 | 12,498 | 12,775 |
| Gross margin (%) | - | - | - | ||||
| Operating margin (%) | - | - | - | ||||
| Operating expenses | - | - | - | 3,493 | 4,233 | 4,468 | 4,510 |
| Operating income | - | - | - | 11,190 | 4,967 | 8,030 | 8,265 |
| Income before tax | 6 | -10 | -54 | 11,211 | 4,953 | 7,841 | 8,220 |
| Pretax margin (%) | - | - | - | 64.2 | 31.6 | 42.5 | 44.1 |
| Provision for income taxes | - | - | - | 3,495 | 1,620 | 2,061 | 1,886 |
| Effective tax rate (%) | - | - | - | ||||
| Net income | 3 | -11 | -55 | 4,481 | 3,035 | 5,774 | 6,315 |
| Earnings per share | 0.03 | -0.11 | -0.55 | 44.81 | 30.35 | 57.74 | 62.07 |
| Diluted EPS | - | - | - | - | - | 53.99 | 58.9 |
| Dividend payout ratio (%) | - | - | - | - | - | ||
| Dividend per share | - | - | - | - | 9 | 27.75 | 28 |